141 to 150 of 352 Results
Adobe PDF - 43.6 KB -
MD5: 08ff08560ac97335d5e0c33ff4d4896a
|
Adobe PDF - 45.1 KB -
MD5: 329c6509dd4bf547dadc39854c56ccbc
|
Tabular Data - 77.5 KB - 8 Variables, 660 Observations - UNF:6:UspLAKlySK4lMU4jeVZ5WA==
|
Adobe PDF - 43.7 KB -
MD5: 540258b091896de6bd128291769be8d7
|
Mar 11, 2024 - ZAN Ping
Zan, Ping; Than, Aung; Leow, Melvin Khee Shing; Cai, Helen Xinyi; Wen, Hanqi; Zhang, Zheye; Chen, Peng, 2024, "Dry powder microneedle-enabled transdermal anti-inflammatory therapy for obesity, diabetes, hyperlipidemia, and fatty liver", https://doi.org/10.21979/N9/GCCTII, DR-NTU (Data), V1
Obese white adipose tissue (WAT) is characterized by hypoxia, oxidative stress, and inflammation, which are the key drivers of various deleterious diseases. Herein, we demonstrate a new strategy to directly induce ameliorative remodeling of obese subcutaneous WAT (sWAT). Manganes... |
Mar 11, 2024 -
Dry powder microneedle-enabled transdermal anti-inflammatory therapy for obesity, diabetes, hyperlipidemia, and fatty liver
JPEG Image - 3.9 MB -
MD5: b463b08acfc110b088e8887096d3b73c
|
Mar 11, 2024 -
Dry powder microneedle-enabled transdermal anti-inflammatory therapy for obesity, diabetes, hyperlipidemia, and fatty liver
JPEG Image - 881.9 KB -
MD5: e33c93290a91cda569908e9931f64bd7
|
Mar 11, 2024 -
Dry powder microneedle-enabled transdermal anti-inflammatory therapy for obesity, diabetes, hyperlipidemia, and fatty liver
JPEG Image - 532.9 KB -
MD5: c0d9ed30518739ce1c61dcb8b1beb70b
|
Mar 11, 2024 -
Dry powder microneedle-enabled transdermal anti-inflammatory therapy for obesity, diabetes, hyperlipidemia, and fatty liver
JPEG Image - 505.4 KB -
MD5: 9bab26996c322a2f5b5d9b98b2e83e74
|
Mar 11, 2024 -
Dry powder microneedle-enabled transdermal anti-inflammatory therapy for obesity, diabetes, hyperlipidemia, and fatty liver
JPEG Image - 7.8 MB -
MD5: 646a42630fadd8a75c628307959f07bc
|
